Acadian Asset Management
CLCD

Acadian Asset Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Acadian Asset Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-840
Closed -$7K – 1656
2016
Q2 		$7K Sell
840
-917
-52% -$6.16K ﹤0.01% 1264
2016
Q1 		$11K Sell
1,757
-874
-33% -$5.46K ﹤0.01% 1187
2015
Q4 		$22K Buy
+2,631
New +$13.8K ﹤0.01% 1162

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Acadian Asset Management's CLCD Position: Q3 2016 in Review

Acadian Asset Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q3 2016, closing a stake of 840 shares — an estimated $7K sold.

Acadian Asset Management first reported a position in CLCD in Q4 2015 and held it in 3 quarters. The position peaked at $22K in Q4 2015. 56 funds tracked by Wall St. Rank hold CLCD as of Q3 2016.

  • Acadian Asset Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Acadian Asset Management sold 840 CoLucid Pharmaceuticals, Inc. shares in Q3 2016, an estimated $7K.
  • Acadian Asset Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2015 and held it in 3 quarters.
  • Acadian Asset Management's CoLucid Pharmaceuticals, Inc. position peaked at $22K in Q4 2015.
  • 56 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q3 2016.

Based on Acadian Asset Management's 13F filing for Q3 2016, filed 20 Oct 2016.